Recent Updates
Recently added Catalysts
SGRY Positive Sentiment

SURGERY PARTNERS, INC. ANNOUNCES ADD-ON

Key Takeaway: Surgery Partners, Inc. announced its intention to offer an additional $425 million in 7.250% senior unsecured notes due 2032, through its subsidiary Surgery Center Holdings, Inc. The proceeds from this offering will be utilized for general corporate purposes, including repaying existing borrowings. As a leading healthcare services company, Surgery Partners aims to enhance its financial stability and support its ongoing operational expansion. However, the success of this offering is contingent on market conditions and carries some inherent risks.
Price reaction · baseline $16.53 (2025-12-10 close) · hit after-hours · 1 other SGRY headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Intention to offer an additional $425 million in senior unsecured notes indicates company growth.
  • Proceeds will be used for general corporate purposes, potentially strengthening the company's financial position.
  • Surgery Partners is a leading healthcare services company and continues to expand its operations.

CONCERNS & RISKS

  • The offering's completion is subject to market conditions and other uncertainties.
  • There is a risk that the proposed offering may not be completed on the anticipated terms or at all.
  • Forward-looking statements are subject to factors that could lead to differing actual results.

Full Press Release Details

SURGERY PARTNERS, INC. ANNOUNCES ADD-ON SENIOR
BRENTWOOD, Tenn., December 11, 2025 (GLOBE NEWSWIRE) - Surgery Partners,
Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator,
announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the "Issuer"), intends to offer,
subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes
due 2032 (the "Notes"). The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic
wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will be issued
as part of the same series as the Issuer's 7.250% senior notes due 2032 originally issued in April 2024.
Surgery Partners intends to use the net proceeds from this
offering for general corporate purposes, including, but not limited to, repaying outstanding borrowings under its revolving credit
This press release shall not constitute an offer to sell or a solicitation
of an offer to buy securities, nor shall there be any offer, solicitation or sale in any jurisdiction in which, or to any person to whom,
such offer, solicitation or sale would be unlawful. The Notes and the Guarantees are being offered and sold only to persons reasonably
believed to be "qualified institutional buyers" in the United States pursuant to Rule 144A under the Securities Act of 1933,
as amended (the "Securities Act"), and to non-U.S. persons outside the United States in reliance on Regulation S under the
Securities Act. The Notes and the Guarantees have not been, and will not be, registered under the Securities Act or any state securities
laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements
of the Securities Act and applicable state laws.
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading
healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions
for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest
and fastest growing surgical services businesses in the country, with more than 200 locations in 30 states, including ambulatory surgery
centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Forward-Looking Statements
This press release contains forward-looking statements, including those
regarding Surgery Partners' intention to offer and sell, and apply the net proceeds of, the Notes. These statements include, but
are not limited to, the Company's expectations regarding the proposed offering. These statements can be identified by the use of
words such as "believes," "anticipates," "expects," "intends," "plans," "continues,"
"estimates," "predicts," "projects," "forecasts," and similar expressions. All forward-looking
statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and other
factors that may cause actual results to differ materially from the expectations discussed in, or implied by, the forward-looking statements.
Many of these factors are beyond our ability to control or predict including, without limitation, the risk that the proposed offering
is not completed on the terms or in the amounts anticipated, or at all, and the other risks and uncertainties identified and discussed
in the Company's reports filed with the SEC, including in Item 1A under the heading "Risk Factors" in the Company's
Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 7, 2025 and the Company's Quarterly Reports on Form
10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, filed on May 12, 2025, August 5, 2025 and November 10,
2025, respectively. Except as required by law, neither the Company nor the Issuer undertakes any obligation to revise or update publicly
any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated
events or circumstances.

Frequently Asked Questions

What is Surgery Partners, Inc. planning to offer?

Surgery Partners intends to offer an additional $425 million in senior unsecured notes.

What is the interest rate on the senior unsecured notes?

The senior unsecured notes have a 7.250% interest rate due in 2032.

How will Surgery Partners use the proceeds from the offering?

The proceeds will be used for general corporate purposes, including debt repayment.

Who can buy the notes being offered?

The notes are offered only to qualified institutional buyers in the U.S.

In which states does Surgery Partners operate?

Surgery Partners operates in 30 states across the U.S.

Last updated: Dec 11, 2025